Wikidata

(Q38432430)

English

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

scientific article published on May 2007

In more languages

Statements

title
KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17504988
retrieved
3 September 2017
author name string
Marileila Varella-Garcia
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17504988
retrieved
3 September 2017
Ximing Tang
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17504988
retrieved
3 September 2017
Ana C Xavier
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17504988
retrieved
3 September 2017
Natalie C Ozburn
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
17504988
retrieved
3 September 2017
Diane D Liu
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
17504988
retrieved
3 September 2017
Benjamin N Bekele
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
17504988
retrieved
3 September 2017
page(s)
2890-2896
1 reference
stated in
Europe PubMed Central
PubMed ID
17504988
retrieved
3 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38432430&oldid=2073823073"